184 related articles for article (PubMed ID: 2440185)
1. [Use of monoclonal antibodies for the intratypic differentiation of strains of poliomyelitis type I virus].
Lashkevich VA; Mustafina AN; Koroleva GA; Gracheva LA; Grishina KG
Vopr Virusol; 1987; 32(2):183-8. PubMed ID: 2440185
[TBL] [Abstract][Full Text] [Related]
2. Intratypic characterization of poliovirus type 1 isolates.
Deshpande JM; Dave KH
Indian J Med Res; 1991 Jul; 93():202-7. PubMed ID: 1660032
[TBL] [Abstract][Full Text] [Related]
3. Characterization of poliovirus isolates in Japan after the mass vaccination with live oral poliomyelitis vaccine (Sabin).
Tagaya I; Nakao C; Hara M; Yamadera S
Bull World Health Organ; 1973 May; 48(5):547-54. PubMed ID: 4359681
[TBL] [Abstract][Full Text] [Related]
4. Intratypic serodifferentiation of poliovirus type 1 strains isolated during outbreaks of paralytic poliomyelitis.
Deshpande JM; Dave KH
Indian J Med Res; 1988 Feb; 87():103-7. PubMed ID: 2840388
[No Abstract] [Full Text] [Related]
5. Determination of type 1 poliovirus subtype classes with neutralizing monoclonal antibodies.
Crainic R; Couillin P; Cabau N; Boue A; Horodniceanu F
Dev Biol Stand; 1981; 50():229-34. PubMed ID: 6176486
[TBL] [Abstract][Full Text] [Related]
6. Neutralization epitope patterns of poliovirus strains isolated from paralytic cases.
Crainic R; Blondel B; Aubert-Combiescu A; Beytout D; Couillin P; Candrea A; Boué A; Horaud F
Dev Biol Stand; 1984; 57():165-70. PubMed ID: 6084607
[TBL] [Abstract][Full Text] [Related]
7. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
8. Antigenic and biochemical characterization of poliovirus type 1 isolates.
Hara M; Arita M; Yamazaki Z; Hagiwara A; Saito Y
Microbiol Immunol; 1987; 31(4):327-36. PubMed ID: 3039316
[TBL] [Abstract][Full Text] [Related]
9. Characterization of strains of type 3 poliovirus by oligonucleotide mapping.
Minor PD
J Gen Virol; 1982 Apr; 59(Pt 2):307-17. PubMed ID: 6281371
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
[TBL] [Abstract][Full Text] [Related]
11. [Antigenic analysis of 100 strains of poliomyelitis type I virus by monoclonal antibody].
Gu FZ
Zhonghua Yu Fang Yi Xue Za Zhi; 1985 Sep; 19(5):265-7. PubMed ID: 3004840
[No Abstract] [Full Text] [Related]
12. Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin.
Hara M; Hagiwara A; Yoneyama T; Saito Y; Shimojo H
Microbiol Immunol; 1983; 27(12):1057-65. PubMed ID: 6328228
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of poliovirus type I isolates in the 1982 epidemic from Sabin-I strain by antigenic and temperature markers.
Lee CN; Kao CL; Lee CY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):80-8. PubMed ID: 3036431
[TBL] [Abstract][Full Text] [Related]
14. Application of monoclonal antibody panels in the virological and epidemiological review of poliomyelitis in Poland, 1981-1990.
Jarzabek Z; Zabicka J; John A; Howlett J; Dunn G; Wood DJ
Bull World Health Organ; 1992; 70(3):327-33. PubMed ID: 1322249
[TBL] [Abstract][Full Text] [Related]
15. Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera.
van Wezel AL; Hazendonk AG
Intervirology; 1979; 11(1):2-8. PubMed ID: 218891
[TBL] [Abstract][Full Text] [Related]
16. Antigenic analysis of polioviruses isolated from a child with agammaglobulinemia and paralytic poliomyelitis after Sabin vaccine administration.
Hara M; Saito Y; Komatsu T; Kodama H; Abo W; Chiba S; Nakao T
Microbiol Immunol; 1981; 25(9):905-13. PubMed ID: 6273701
[TBL] [Abstract][Full Text] [Related]
17. Long-term excretion of vaccine-derived poliovirus by a healthy child.
Martín J; Odoom K; Tuite G; Dunn G; Hopewell N; Cooper G; Fitzharris C; Butler K; Hall WW; Minor PD
J Virol; 2004 Dec; 78(24):13839-47. PubMed ID: 15564492
[TBL] [Abstract][Full Text] [Related]
18. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
[TBL] [Abstract][Full Text] [Related]
19. Antigenic and biochemical characterization of poliovirus type 2 isolated from two cases of paralytic disease.
Fiore L; Pierangeli A; Lombardi F; Santoro R; Crainic R; Venuti A; Perez-Bercoff R
Intervirology; 1987; 27(4):196-204. PubMed ID: 2447031
[TBL] [Abstract][Full Text] [Related]
20. Production and characterization of neutralizing monoclonal antibodies against poliovirus type 1, 2, and 3.
Payment P; Trudel M; Thibodeau L; Lecomte J
Can J Microbiol; 1989 May; 35(5):550-3. PubMed ID: 2545322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
